Fmr LLC Has $686,000 Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Fmr LLC boosted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,940 shares of the exchange traded fund’s stock after purchasing an additional 830 shares during the quarter. Fmr LLC’s holdings in SPDR S&P Biotech ETF were worth $686,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of the business. Clal Insurance Enterprises Holdings Ltd acquired a new stake in shares of SPDR S&P Biotech ETF in the third quarter valued at approximately $141,284,000. Northwestern Mutual Wealth Management Co. increased its stake in SPDR S&P Biotech ETF by 1.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after acquiring an additional 18,202 shares during the period. Mirae Asset Securities USA Inc. raised its holdings in SPDR S&P Biotech ETF by 50.0% in the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock valued at $88,920,000 after acquiring an additional 300,000 shares in the last quarter. Employees Retirement System of Texas lifted its position in shares of SPDR S&P Biotech ETF by 40.8% during the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock valued at $55,984,000 after acquiring an additional 174,857 shares during the period. Finally, Main Management Fund Advisors LLC grew its holdings in shares of SPDR S&P Biotech ETF by 8.3% during the 2nd quarter. Main Management Fund Advisors LLC now owns 598,200 shares of the exchange traded fund’s stock worth $55,459,000 after purchasing an additional 45,700 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA XBI opened at $94.59 on Wednesday. The stock has a market capitalization of $7.21 billion, a P/E ratio of 11.47 and a beta of 1.11. The stock’s fifty day moving average is $97.96 and its 200 day moving average is $97.21. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.